OpenAI Buys Drug Development Company Orchestra Bio

T1Covered by 1 source · first reported by The Information (teasers) at 20 Oct, 19:54 UTC

OpenAI is buying Orchestra Bio, a startup that builds AI agents to help biotech and pharmaceutical companies with drug development, the AI lab announced on Tuesday. The acquisition is an early move toward a goal long-touted by OpenAI executives of using the company’s technology to help with ...